SMITH SCOTT THOMAS
EVP & Chief Financial Officer
SMITH SCOTT THOMAS has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 2, 2026.
On the most recent filing, SMITH SCOTT THOMAS is listed as EVP & Chief Financial Officer at Ascendis Pharma A/S. Inside the rolling window, SMITH SCOTT THOMAS reported 2 open-market purchases totaling $78K in ASND and no open-market sales. The largest disclosed transaction in the window is a purchase of 250 ASND shares on May 29, 2026, worth $56K.
Companies traded
Other insiders at ASND
Insider Buying
$78K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has SMITH SCOTT THOMAS made?
SMITH SCOTT THOMAS has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does SMITH SCOTT THOMAS trade?
SMITH SCOTT THOMAS has filed SEC Form 4 disclosures for 1 company, including ASND.
When was SMITH SCOTT THOMAS's most recent SEC Form 4 filing?
SMITH SCOTT THOMAS's most recent SEC Form 4 filing on Tracefour is dated Jun 2, 2026.
What is SMITH SCOTT THOMAS's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, SMITH SCOTT THOMAS is listed as EVP & Chief Financial Officer.
What is SMITH SCOTT THOMAS's total buy and sell value in the current window?
Inside the rolling retention window, SMITH SCOTT THOMAS bought $78K and sold $0 based on SEC Form 4 filings.
What was SMITH SCOTT THOMAS's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 250 ASND shares on 2026-05-29, worth $56K, per SEC Form 4 filings.